Company Overview of Hydron Technologies Inc.
Hydron Technologies, Inc., through its 50% investment in the joint venture, Brand Builders Rx, LLC, focuses on designing, marketing, selling, and managing certain technologies and products in the United States. It owns and licenses its patented intellectual property, oxygenation technology, that provides a method for delivering oxygen into the skin and tissue at depths considered medically therapeutic. The company was founded in 1948 and is based in Saint Petersburg, Florida.
9843 18th Street North
St Petersburg, FL 33716
Founded in 1948
Key Executives for Hydron Technologies Inc.
Hydron Technologies Inc. does not have any Key Executives recorded.
Hydron Technologies Inc. Key Developments
SEC Revokes Registration Of Securities Of Hydron Technologies For Failure To Make Required Periodic Filings
Jul 24 14
Securities and Exchange Commission (SEC or the commission) revoked the registration of each class of registered securities of Hydron Technologies, Inc. for failure to make required periodic filings with the Commission. SEC reported that the company failed to comply with Section 13(a) of the Securities Exchange Act of 1934 (Exchange Act and Rules 13a-1 and 13a-13 there under and revoking the registration of each class of the company’s securities pursuant to Section 12(j) of the Exchange Act.
SEC Orders Hearings On Registration Suspension Or Revocation Against Hydron Technologies, Inc. For Failure To Make Required Periodic Filings
Jun 24 14
Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Hydron Technologies, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries